Breast Cancer Clinical Trials in Glendale, AZ

Breast Cancer Clinical Trials in Glendale, AZ

View the best 10 breast cancer medical studies in Glendale, Arizona. Access promising new therapies by applying to a Glendale-based Breast Cancer clinical trial.

Trials in Glendale, Arizona

Here are the top 10 medical studies for breast cancer in Glendale, Arizona

Image of Palo Verde Hematology Oncology in Glendale, United States.

Capecitabine +2 More

Antimetabolites

Recruiting2 awardsPhase 3
This trial will test if a new combination of drugs is more effective and safer than standard treatments for triple negative breast cancer.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

WBI

Radiation Therapy

Recruiting1 award17 criteria
This trial is comparing two types of radiation therapy to treat early-stage breast cancer.
Image of Southern Cancer Center PC-Mobile in Mobile, United States.

Paclitaxel +2 More

Anti-metabolites

Recruiting2 awardsPhase 3
This trial is testing two different chemotherapy combinations to treat triple negative breast cancer to see which is more effective.
Image of Northwestern Medicine Cancer Center in Warrenville, United States.

TOL2506

Hormone Therapy

Recruiting2 awardsPhase 3
This trial tests TOL2506, a treatment that stops ovaries from working, in premenopausal women and men with hormone-sensitive breast cancer. It aims to reduce hormone levels to slow down or stop cancer growth. TOL2506 is a treatment that stops ovaries from working, similar to other ovarian suppression methods.
Image of Arizona Oncology Associates, PC - HAL in Phoenix, United States.

Fulvestrant +2 More

Estrogen Receptor Antagonist

Recruiting1 awardPhase 2
This trial is for people with solid tumors that make too much HER2 or a different type of HER2. Participants will get tucatinib and trastuzumab. People with hormone-receptor positive breast cancer will also get fulvestrant. The trial will look at side effects.
Image of Banner Health/Banner Research in Phoenix, United States.

Whole Breast Irradiation

Recruiting1 award3 criteria
This trial is testing whether eliminating surgery and just using radiation therapy after systemic therapy works well in treating patients with HER2 positive or triple negative breast cancer.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Ulixertinib +18 More

Kinase Inhibitor

Recruiting1 awardPhase 2
This trial uses genomic testing to direct cancer treatment. Patients with cancer that has progressed after standard treatment or for which there is no agreed-upon treatment may benefit.
Image of University of South Alabama Mitchell Cancer Institute in Mobile, United States.

Standard Adjuvant Endocrine Therapy

Endocrine Therapy

Recruiting2 awardsPhase 3
This trial is testing whether adding the drug palbociclib to standard hormone therapy can improve treatment for patients with a specific type of early breast cancer. The targeted patients have hormone receptor-positive and HER2-negative breast cancer. Palbociclib works by blocking proteins that help cancer cells grow, potentially making the hormone therapy more effective.
Image of UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, United States.

9-ING-41

GSK-3β inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug to see if it is safe and effective in treating cancer. The drug is designed to target a protein called GSK-3β, which is found in many different types of cancer cells.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Pembrolizumab

Recruiting2 awardsPhase 3
This trial studies pembrolizumab to see how well it works in treating triple-negative breast cancer.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.